The Centers for Disease Control and Prevention today released an advisory recommending clinicians expedite subtyping of type A influenza samples from hospitalized patients, particularly individuals in an intensive care unit.

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers wrote.

Amesh Adalja, an infectious disease and senior scholar at Johns Hopkins Center for Health Security, told Salon H5N1 and other avian influenza viruses are a type A influenza virus. "We do need subtype confirmation ... viruses.” In Louisiana, the patient ...

The findings come at a time when outbreaks of bird flu -- a different subtype of the ... of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating

This pathogenic avian influenza A is a subtype that is found in cows ... with highly pathogenic avian influenza (HPAI) A, H5N1 virus that primarily causes bird flu, has a high potential for ...

Officials from the Centers for Disease Control and Prevention (CDC) recommend that hospitals speed up testing people who are hospitalized with the flu for H5N1 bird flu. Health care workers in

Its alert to doctors and hospitals follows a few rare but mysterious bird flu cases in the US – including, most recently, a child in San Francisco confirmed to have had H5N1 influenza – that ...

A case of the bird flu (also known avian flu or H5N1) involving gamebirds has been confirmed in Spartanburg. The virus was first detected on Dec. 31 and has not been transmitted elsewhere in the Carolinas, the Centers for Disease Control (CDC) reports.

Is it seasonal flu or bird flu? CDC prompts hospitals to fast-track subtype testing of sick patients to tell the difference.

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

The U.S. Centers for Disease Control and Prevention is asking that people with flu severe enough to require hospitalization be tested for bird flu.

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.